Genetically Engineered Mouse Models Support a Major Role of Immune Checkpoint-Dependent Immunosurveillance Escape in B-Cell Lymphomas.

Frontiers in Immunology
Quentin LemassonChristelle Vincent-Fabert

Abstract

These last 20 years, research on immune tumor microenvironment led to identify some critical recurrent mechanisms used in cancer to escape immune response. Through immune checkpoints, which are cell surface molecules involved in the immune system control, it is now established that tumor cells are able to shutdown the immune response. Due to the complexity and heterogeneity of Non Hodgkin B-cell Lymphomas (NHBLs), it is difficult to understand the precise mechanisms of immune escape and to explain the mitigated effect of immune checkpoints blockade for their treatment. Because genetically engineered mouse models are very reliable tools to improve our understanding of molecular mechanisms involved in B-cell transformation and, at the same time, can be useful preclinical models to predict immune response, we reviewed hereafter some of these models that highlight the immune escape mechanisms of NHBLs and open perspectives on future therapies.

References

May 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Roberta BichiCarlo M Croce
May 21, 2008·The Journal of Experimental Medicine·Cornelia Hömig-HölzelUrsula Zimber-Strobl
Sep 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Georg LenzLouis M Staudt
Dec 2, 2009·European Journal of Immunology·Christoph D BrennerRalph Mocikat
Dec 24, 2010·Nature·Vu N NgoLouis M Staudt
Apr 5, 2012·Clinical & Developmental Immunology·Rishi Vishal LuckheeramBing Xia
Jun 26, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julia HilpertHelmut Rainer Salih
May 16, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin J ChenScott J Rodig
Jul 8, 2015·European Journal of Immunology·Lena BeltingRalph Mocikat
Jul 28, 2016·Oncogene·A MaromI Shachar
Aug 10, 2016·Seminars in Cancer Biology·Valeria Spina, Davide Rossi
Nov 25, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephen M Ansell
Jan 20, 2017·Nature·Daniel S Chen, Ira Mellman
Feb 25, 2017·Haematologica·Amandine DavidNathalie Faumont
Jul 19, 2017·Cancer Research·Andreas HerrmannHua Yu
Aug 24, 2017·Proceedings of the National Academy of Sciences of the United States of America·Hind HashwahAnne Müller
Nov 10, 2017·Blood·Zijun Y Xu-MonetteKen H Young
Mar 23, 2018·Frontiers in Oncology·Thomas Menter, Alexandar Tzankov
Jun 1, 2018·Journal of Immunology Research·Magdalena Witkowska, Piotr Smolewski
Sep 17, 2018·Biophysical Journal·Sahamoddin KhailaieMichael Meyer-Hermann
Sep 27, 2018·Frontiers in Oncology·Jun ZhangKen H Young
Oct 3, 2018·The Journal of Clinical Investigation·Hadas LewinskyIdit Shachar
Jan 9, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen M AnsellAndrew Grigg
Jan 13, 2019·Cellular & Molecular Immunology·Christelle Vincent-FabertNathalie Faumont
Mar 16, 2019·Immunological Reviews·Adi BiramZiv Shulman
Mar 27, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Priscilla DoJohn C Byrd

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Rinsho byori. The Japanese journal of clinical pathology
Hiroyasu Ito
Revue des maladies respiratoires
A-G GoubetE Romano
Biomedicines
Stephen D H MalnickManuela G Neuman
© 2021 Meta ULC. All rights reserved